Save Time and Lives in R&D with Sinequa Scientific Search

The Scientific Knowledge Problem in Pharmaceutical R&D

Pharmaceutical R&D organizations are among the most knowledge-intensive enterprises in the world. A single drug development program generates thousands of experimental results, literature references, regulatory documents, formulation records, and safety observations across its lifecycle. A large pharma organization running dozens of concurrent programs across multiple therapeutic areas generates this at a scale that no manual knowledge management approach can organize effectively.

The problem this creates is not data scarcity — it is knowledge inaccessibility. The data exists. The insights it contains exist. The question is whether researchers can locate and act on those insights at the point of need: when a medicinal chemist is designing the next analogue series, when a pharmacologist is selecting an assay cascade for a new target, when a regulatory scientist is preparing a submission and needs to locate prior agency responses on analogous safety questions.

Scientific search is the infrastructure layer that makes this possible. It is distinct from general enterprise search in two important ways. First, it handles the specific data types of scientific R&D: structured assay data, compound registration records, genomic annotations, experimental protocols, ELN entries, LIMS records, and scientific literature — not just document files and email. Second, it applies semantic understanding tuned to scientific vocabulary — understanding that a query about a specific kinase target is also relevant to assay results, patent filings, literature, and internal compound data associated with that target, even when the query uses different terminology than the source documents.

The consequence of poor scientific search is measurable in two dimensions that matter directly to drug development economics: duplicated research effort (running experiments that have already been run because the results are not findable) and delayed decision-making (slower TPP creation, longer target validation cycles, less-informed go/no-go decisions). Both compound across programs and across the R&D portfolio.

What Is Sinequa Scientific Search?

Sinequa Scientific Search is an AI-powered search platform purpose-built for pharmaceutical and life sciences R&D environments. It connects the full range of scientific data sources that drug discovery and development teams depend on — applying machine learning to understand scientific queries, surface relevant information across all connected sources simultaneously, and enable researchers to find the connections and patterns that accelerate R&D decisions.

• Electronic Lab Notebooks (ELNs) and LIMS. Experimental data generated in ELNs and Laboratory Information Management Systems is among the most valuable and least accessible knowledge in pharmaceutical R&D. Sinequa indexes ELN entries and LIMS records — structured and semi-structured experimental data — making them searchable alongside documents, literature, and database records in a unified query interface.
• Public scientific databases. Drug discovery researchers depend on external data sources: PubMed, patent databases, clinical trial registries, genomic databases, protein structure repositories, and compound libraries. Sinequa connects to public scientific databases alongside internal sources, enabling researchers to search across internal experimental results and external literature simultaneously — without switching between systems or reconciling results from separate searches.
• Proprietary compound and target databases. Internal compound registration systems, target libraries, and safety databases contain the accumulated intellectual property of the organization’s R&D history. Sinequa indexes these proprietary sources with the security controls required to protect IP — ensuring that researchers can find relevant compound data and prior safety observations without exposing sensitive records to unauthorized access.
• Scientific literature and regulatory documents. Publications, patents, regulatory submissions, and internal scientific reports form the contextual backbone of any R&D program. Sinequa applies NLP models trained on scientific and biomedical language to extract entities (genes, proteins, compounds, indications, mechanisms) and relationships from unstructured text — making scientific literature as searchable by concept and relationship as structured database records.

How Scientific Search Accelerates the Drug Discovery and Development Lifecycle

The value of AI-powered scientific search is realized at specific, identifiable points in the R&D lifecycle — not as a general productivity improvement, but as a decision-quality and decision-speed accelerator at the stages where information gaps are most costly.

• Target identification and validation. Early-stage drug discovery requires rapid synthesis of information about potential targets: existing literature on target biology, internal experimental data from prior programs, competitive patent landscape, and safety signals from related targets. Scientific search that spans all of these sources enables target assessment that would take weeks of manual literature review to complete in hours — directly compressing the timeline from hypothesis to validated target.
• Target Product Profile (TPP) creation. The TPP is the strategic document that defines what a successful drug candidate must achieve — and its quality depends on the completeness of the information that informs it. Prior clinical data, competitive product profiles, patient population data, and regulatory precedent all contribute. Organizations with unified scientific search infrastructure create TPPs grounded in the full body of available evidence; organizations without it create TPPs based on whatever their teams can find manually in the time available.
• Hit identification and lead optimization. Medicinal chemistry teams designing new compound series need rapid access to SAR (structure-activity relationship) data from prior programs, assay results for related scaffolds, and ADMET profiles for analogous compounds. Scientific search that connects compound databases, assay repositories, and ELN data enables chemists to build on prior work rather than repeat it — a direct reduction in synthesis cycles and assay campaigns.
• Safety and regulatory intelligence. Throughout development, safety teams and regulatory scientists need to locate prior observations — both internal and in published literature — on safety signals, metabolite profiles, drug-drug interaction patterns, and regulatory precedent. The speed and completeness with which these searches can be conducted affects both the quality of safety assessments and the efficiency of regulatory submission preparation.

Scientific Search vs. Clinical Data Search — Understanding the Distinction

Sinequa serves the pharmaceutical R&D lifecycle with two complementary search capabilities that address different data environments and different user communities.

• Sinequa Scientific Search is designed for the drug discovery and early development environment: ELNs, LIMS, compound databases, scientific literature, target and assay repositories, and public scientific databases. Its users are research scientists, medicinal chemists, pharmacologists, and R&D informatics teams. Its primary use cases are target identification, compound selection, SAR analysis, and scientific literature synthesis.
• Sinequa Clinical Data Search is designed for the clinical development environment: SAS analysis datasets, clinical study reports, protocols, regulatory submission archives, and clinical databases. Its users are clinical statisticians, data managers, and clinical operations teams. Its primary use cases are historical study analysis, protocol design support, and regulatory intelligence.

The two capabilities share the same underlying platform architecture — unified retrieval, semantic understanding, enterprise-grade security, and multi-source connectivity — but are configured for the distinct data types, vocabularies, and workflow patterns of their respective user communities. For organizations that operate across both discovery and clinical development, both capabilities can be deployed on the same Sinequa platform.